As part of an indiscriminate sell-off, CaixaBank’s share price moved in tandem with the rest of the sector until the summer, when it started to overperform (+7% ytd) ahead of the…

The mood music stopped about six months ago on a pre-COVID-19 high (19/02). It pays to group stocks into: a) those which, six months later, outperform their pre-COVID-19 highs, and…

With central banks’ liquidity guns in action over the last three months, it is worth checking the successful long-short trades. This is obviously ex post work but it may give an extra…

AlphaValue’s Buy & Hold Portfolio continues to surprise on the positive side. The ytd outperformance is 15% so that it is down only 2% in absolute terms. Over the last…

AlphaValue has maintained over the last 6 years a Buy & Hold list of 25 names which has consistently outperformed. There is hardly ever any change to that list as a quality…

We still hold the view that a second leg of price correction is likely, now that the extent of stimuli across the world is known/discounted while investors understand somewhat better…

When we last teased about Sonova in September 2018, the world’s No.1 hearing aids manufacturer’s first generation Made-for-All/MFA product (offers iPhone and Android connectivity) was struggling to find traction. If…

FCA and PSA announced at the end of October that they are in serious negotiations to merge as equals. Since then, FCA’s shares have appreciated c. 11%. Simultaneously, PSA’s shares…

Iliad the French telco that moved from growth darling to staid also ran in a matter of five years is today launching a curious deal whereby it proposes to buy…

According to the media, Euronext is exploring a bid on European stock exchanges, among which BME and Borsa Italiana. This has been in the air for a long time but…